This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Dorfman, G. S. PubMed PubMed Citation Articles by Dorfman, G. S. Related Collections Clinical Research Clinical Research: Clinical Trials

The Translational Research Working Group Developmental Pathway for Interventive Devices

Authors' Affiliations: ¹ Weill Cornell Medical College, New York, New York; ² University of Michigan, Ann Arbor, Michigan; and ³ Vanderbilt University, Nashville, Tennessee

Requests for reprints: Lynn M. Matrisian, Department of Cancer Biology, Vanderbilt University, 771 PRB, 2220 Pierce Avenue, Nashville, TN 37232-6840. Phone: 615-322-0375; Fax: 615-936-2911; E-mail: Lynn.matrisian{at}vanderbilt.edu.

Abstract

The interventive device pathway refers to one of six pathways developed by the Translational Research Working Group (TRWG) that, together, describe the core domains of early translational cancer research. This pathway focuses on the development of devices (as classified by the Food and Drug Administration), designed for local ablation of cancer or precancerous lesions (e.g., radiation therapy, microwave, radiofrequency ablation, and high-intensity focused ultrasound systems). This article describes the distinctive features of the pathway and issues that are encountered in the real-world development of interventive devices for the treatment of cancer. The interventive device pathway is envisioned to be a general guideline of the steps required for effective development, optimization, testing, and validation of developing devices, to be dynamic and adaptable, and to form a framework for discussions focused on improving the efficiency and effectiveness of new device development.

This article has been cited by other articles:

				G. S. Dorfman, D. C. Sullivan, M. D. Schnall, L. M. Matrisian, and for the Translational Research Working Group The Translational Research Working Group Developmental Pathway for Image-Based Assessment Modalities Clin. Cancer Res., September 15, 2008; 14(18): 5678 - 5684. [Abstract] [Full Text] [PDF]

				E. T. Hawk, L. M. Matrisian, W. G. Nelson, G. S. Dorfman, L. Stevens, J. Kwok, J. Viner, J. Hautala, O. Grad, and for the Translational Research Working Group The Translational Research Working Group Developmental Pathways: Introduction and Overview Clin. Cancer Res., September 15, 2008; 14(18): 5664 - 5671. [Abstract] [Full Text] [PDF]

				G. C. Prendergast Cancer Research: Historical Overviews and Better Translational Pathways Cancer Reviews Online Content, January 1, 2008; 2008(10): 19 - 20. [Full Text] [PDF]